"Electrophoresis Equipment and Supplies Market to Exhibit Healthy Growth during the Forecast Period from 2021 to 2029"
The global electrophoresis equipment and supplies market accounted for a value of US$ 1,957.4 Mn in 2020 and expected to attain US$ 2,891.5 Mn by 2029. Factors characterizing the market growth are worldwide rising prevalence of cancer, genetic disorders, and infectious diseases, increasing research activities coupled with funding in the proteomics and genomics fields, surging number of industry-academic research institutes collaborations, and growing focus on next-generation sequencing (NGS) research activities. Furthermore, changing regulatory requirements in the healthcare sector and mounting need to curb healthcare expenditure across the world are likely to nurture the market growth. Growing demand for innovative drugs and therapies is facilitating the demand for drug discovery research and increasing research projects related to proteins and genes. On the contrary, the presence of alternative technologies to electrophoresis that provides better efficiency and outcomes are expected to limit the adoption of electrophoresis technique over the forecast period. In addition, electrophoresis is a time-consuming technique and provides limited sample analysis are anticipated to hinder the market growth in the near future.
"The Electrophoresis Supplies & Accessories Segment to Command the Market from 2021 to 2029"
Electrophoresis supplies & accessories segment is further categorized into buffers & reagents, power supplies, and others such as films, solutions, vacuum pumps, combs, densitometers, cassettes, among others. This segment dominated the market in 2020 due to repetitive usage and purchase of electrophoresis supplies & accessories. The gel electrophoresis systems segment would also hold substantial market share during the forecast period attributed to rising applications in proteomics & genomics.
"The Quality Control & Process Validation Segment is Expected to Register Fastest Market Growth Over the Forecast Period From 2021 to 2029"
Rising applications of electrophoresis in quality control of pharmaceutical formulations by assaying the drug content of pharmaceutical formulations is expected to assist in the healthy market growth over the forecast period. Electrophoresis is used in the identification and study of deoxyribonucleic acid (DNA) and DNA fragments, and testing of antibiotics & vaccines. Electrophoresis is used to test the purity of an antibiotic that enables researchers to differentiate between antibiotic and any impurities present. Moreover, the electrophoresis is useful in the vaccines creation and production. The technique is used by researchers to compare the effect of vaccines across a large number of test subjects.
"North America led the Market in 2020 due to the Presence of Supportive Healthcare Infrastructure and Presence of Major Market Players"
North America is expected to dominate the market throughout the forecast period owing to the domicile of key market participants, rising technological advances in electrophoresis coupled with growing adoption of technologies, and a procedural shift towards combination techniques. Additionally, rising research & developments and the presence of rigorous regulatory requirements regarding pharmaceutical manufacturing that demanding quality control and process validation processes.
Asia Pacific to register the fastest market growth over the forecast period due to the presence of improved healthcare infrastructure and increasing investments in research capacities in drug & therapy discovery. Moreover, surging number of academic & research institutes and pharmaceutical & biotechnology industries in India, China, Japan, and Australia would kindle the demand for electrophoresis equipment & supplies in the near future.
"The Presence of International Market Players Creates Market Penetration Challenging for New Entrants"
Key companies in this vertical are Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; Agilent Technologies, Inc.; Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation); PerkinElmer Inc.; Shimadzu Corporation; Merck KGaA; QIAGEN; and Helena Laboratories. These leading market value contributors are adopting organic & inorganic business growth strategies such as new product launches, joint ventures (JVs), vertical & horizontal integration, collaborations & partnerships, mergers & acquisitions (M&As), divestitures, and operational & geographical expansions. In March 2021, Thermo Fisher Scientific Inc. acquired IntegenX, a U.S.-based provider of Rapid DNA technology for human identification in forensics and law enforcement applications in order to complement capillary electrophoresis systems. Moreover, in May 2020, Thermo Fisher Scientific Inc. launched Applied Biosystems SeqStudio Genetic Analyzer, a capillary electrophoresis (CE) platform that provides a low-throughput, cartridge-based system for Sanger sequencing and fragment analysis in genome editing, oncology research, species identification, and human cell line authentication.
This report also incorporates the qualitative analysis of market dynamics/variables such as key market drivers, restraints, opportunities, and trends which provide complete market information of the overall electrophoresis equipment and supplies industry. Also, the report also includes a graphical demonstration of the competitive landscape based on their market initiatives & strategies, product portfolio, financial information, and key developments. Major market contributors profiled in this report are Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; Agilent Technologies, Inc.; Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation); PerkinElmer Inc.; Shimadzu Corporation; Merck KGaA; QIAGEN; and Helena Laboratories.
Historical & Forecast Period
This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Electrophoresis Equipment And Supplies market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2023-2033 |
Base Year | 2024 |
Forecast Period | 2025-2033 |
Historical Year | 2023 |
Unit | USD Million |
Segmentation | |
Product
| |
Application
| |
Region Segment (2023-2033; US$ Million)
|
Key questions answered in this report